Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study

Guangyin Zhao(The First Affiliated Hospital, Sun Yat-sen University), Di Ge(University of Jinan), Chunlai Lu(Zhongshan Hospital), Jie Gu(University of Nottingham Ningbo China), Teng Ma(Fudan University), Hongyu Zhang(Dongguan People’s Hospital), Qiaoliang Zhu(Sun Yat-sen University), Fengkai Xu(Zhongshan Hospital), Duilio Divisi(University of L'Aquila), Francesco Grossi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Translational Lung Cancer Research
January 1, 2023
10.21037/tlcr-22-871
Cited by 12

Related Papers

Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|454
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
|Trends in Food Science & Technology|2023|286
Whole-genome sequencing of six dog breeds from continuous altitudes reveals adaptation to high-altitude hypoxia
|Genome Research|2014|227
Probiotic consumption relieved human stress and anxiety symptoms possibly via modulating the neuroactive potential of the gut microbiota
|Neurobiology of Stress|2021|147
The meconium microbiota shares more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota
|Gut Microbes|2020|142